+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

AngioDynamics Inc (ANGO) - Product Pipeline Analysis, 2026 Update

  • PDF Icon

    Company Profile

  • 109 Pages
  • October 2026
  • GlobalData
  • AngioDynamics
  • ID: 5726064

Summary

AngioDynamics Inc (AngioDynamics) designs, manufactures and markets minimally invasive and image-guided therapeutics and diagnostic devices. Its product portfolio encompasses vascular products, radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories, products for dialysis, angioplasty, drainage, thrombolysis and embolization, as well as venous products and renal therapy products. The company’s products find application in interventional radiology, interventional cardiology, and minimally invasive diagnosis and treatment of cancer and peripheral vascular disease. It sells its products through direct sales force in the US and through a network of distributors outside the US, which include Latin America, Europe, Asia, and others. AngioDynamics is headquartered in Latham, New York, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company AngioDynamics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

  • AngioDynamics Inc Company Overview
  • AngioDynamics Inc Company Snapshot
  • AngioDynamics Inc Pipeline Products and Ongoing Clinical Trials Overview
  • AngioDynamics Inc - Pipeline Analysis Overview
  • Business Description
  • AngioDynamics Inc - Key Facts
  • AngioDynamics Inc - Major Products and Services
  • AngioDynamics Inc Pipeline Products by Development Stage
  • AngioDynamics Inc Ongoing Clinical Trials by Trial Status
  • AngioDynamics Inc Pipeline Products Overview
  • Acuswift
  • Acuswift Product Overview
  • AlphaReturn Blood Management System
  • AlphaReturn Blood Management System Product Overview
  • AlphaReturn Blood Management System Clinical Trial
  • Alphavac F13 10
  • Alphavac F13 10 Product Overview
  • Alphavac F14 20
  • Alphavac F14 20 Product Overview
  • AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System
  • AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System Product Overview
  • AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System Clinical Trial
  • AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System
  • AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System Product Overview
  • AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System Clinical Trial
  • Alphavac System - Infective Endocarditis
  • Alphavac System - Infective Endocarditis Product Overview
  • Alphavac System - Left Atrial Appendage Thrombus
  • Alphavac System - Left Atrial Appendage Thrombus Product Overview
  • AngioVac - Generation 4
  • AngioVac - Generation 4 Product Overview
  • AngioVac - Left Heart
  • AngioVac - Left Heart Product Overview
  • AngioVac Low Profile Catheter
  • AngioVac Low Profile Catheter Product Overview
  • AngioVac System - Infective Endocarditis
  • AngioVac System - Infective Endocarditis Product Overview
  • AngioVac System - Infective Endocarditis Clinical Trial
  • AURYON Atherectomy System - Gastrointestinal Procedures
  • AURYON Atherectomy System - Gastrointestinal Procedures Product Overview
  • AURYON Atherectomy System - Iliofemoral Deep Vein Thrombosis (DVT)
  • AURYON Atherectomy System - Iliofemoral Deep Vein Thrombosis (DVT) Product Overview
  • AURYON Atherectomy System - Lead Extraction
  • AURYON Atherectomy System - Lead Extraction Product Overview
  • AURYON Atherectomy System - Venous Disease
  • AURYON Atherectomy System - Venous Disease Product Overview
  • AURYON System - Small Vessel Thrombectomy
  • AURYON System - Small Vessel Thrombectomy Product Overview
  • Automated Fluid Management System
  • Automated Fluid Management System Product Overview
  • BioFlo PICC Line Extension
  • BioFlo PICC Line Extension Product Overview
  • BioFlo Portline Line Extension
  • BioFlo Portline Line Extension Product Overview
  • Coronary Angio Catheter
  • Coronary Angio Catheter Product Overview
  • FireFly Tip Location
  • FireFly Tip Location Product Overview
  • Inflation Device
  • Inflation Device Product Overview
  • Mechanical Thrombectomy Device
  • Mechanical Thrombectomy Device Product Overview
  • Multi-Purpose Mechanical Aspiration Gen 2
  • Multi-Purpose Mechanical Aspiration Gen 2 Product Overview
  • NanoKnife 3.0 System - Liver Cancer
  • NanoKnife 3.0 System - Liver Cancer Product Overview
  • NanoKnife 3.0 System - Pancreatic Cancer
  • NanoKnife 3.0 System - Pancreatic Cancer Product Overview
  • NanoKnife 3.0 System - Prostate Cancer
  • NanoKnife 3.0 System - Prostate Cancer Product Overview
  • NanoKnife System - Benign Prostatic Hyperplasia
  • NanoKnife System - Benign Prostatic Hyperplasia Product Overview
  • NanoKnife System - Benign Prostatic Hyperplasia Clinical Trial
  • Nanoknife System - Bladder Cancer
  • Nanoknife System - Bladder Cancer Product Overview
  • NanoKnife System - Cervical Cancer
  • NanoKnife System - Cervical Cancer Product Overview
  • NanoKnife System - Head And Neck Cancer
  • NanoKnife System - Head And Neck Cancer Product Overview
  • NanoKnife System - Hepatocellular Carcinoma
  • NanoKnife System - Hepatocellular Carcinoma Product Overview
  • NanoKnife System - Hepatocellular Carcinoma Clinical Trial
  • NanoKnife System - Lung Cancer
  • NanoKnife System - Lung Cancer Product Overview
  • Nanoknife System - Metastatic Lymph Nodes
  • Nanoknife System - Metastatic Lymph Nodes Product Overview
  • NanoKnife System - Rectal Cancer
  • NanoKnife System - Rectal Cancer Product Overview
  • NanoKnife System - Stage III Pancreatic Cancer
  • NanoKnife System - Stage III Pancreatic Cancer Product Overview
  • NanoKnife System - Stage III Pancreatic Cancer Clinical Trial
  • Nanoknife System - Stomach Neoplasm
  • Nanoknife System - Stomach Neoplasm Product Overview
  • Nanoknife System - Unresectable Renal Pelvis Urothelial Neoplasm
  • Nanoknife System - Unresectable Renal Pelvis Urothelial Neoplasm Product Overview
  • Next Gen Tumescent Delivery Device
  • Next Gen Tumescent Delivery Device Product Overview
  • Next Generation BioFlo PICC
  • Next Generation BioFlo PICC Product Overview
  • Next Generation BioFlo Port
  • Next Generation BioFlo Port Product Overview
  • Next Generation Dialysis Device
  • Next Generation Dialysis Device Product Overview
  • Next Generation Laser
  • Next Generation Laser Product Overview
  • Next Generation Radio Frequency Ablation System
  • Next Generation Radio Frequency Ablation System Product Overview
  • Non-Thermal Vein Ablation Device
  • Non-Thermal Vein Ablation Device Product Overview
  • Peripheral Vascular Drainage Line Extension
  • Peripheral Vascular Drainage Line Extension Product Overview
  • POWERWAVE
  • POWERWAVE Product Overview
  • Smart Port - Dual
  • Smart Port - Dual Product Overview
  • Ultrasound-Assisted Thrombectomy System
  • Ultrasound-Assisted Thrombectomy System Product Overview
  • AngioDynamics Inc - Key Competitors
  • AngioDynamics Inc - Key Employees
  • AngioDynamics Inc - Key Employee Biographies
  • AngioDynamics Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • AngioDynamics Inc, Recent Developments
  • Oct 14, 2026: Angiodynamics Announces Humana Medicare Advantage Coverage Policy Supporting Broader Access to NanoKnife IRE for Prostate and Liver Cancer
  • Aug 28, 2026: Early Alert: Angiographic Catheter Issue from Boston Scientific
  • Jun 18, 2026: AngioDynamics secures FDA approval for RELIEF study of NanoKnife
  • May 28, 2026: AngioDynamics Expands Patient Access to NanoKnife IRE for Prostate and Liver Cancer as Medicare Coverage Framework Takes Effect
  • May 14, 2026: AngioDynamics reports PRESERVE trial results for NanoKnife system
  • Apr 06, 2026: AngioDynamics Receives Additional 510(K) Clearance For NanoKnife System
  • Feb 23, 2026: AngioDynamics to Present at the Leerink Partners Global Healthcare Conference
  • Feb 20, 2026: AngioDynamics expands European indications for NanoKnife system
  • Feb 20, 2026: AngioDynamics expands European indications for NanoKnife system
  • Feb 05, 2026: AngioDynamics and the PERT Consortium Launch Investigator-Led Research Fund To Advance Pulmonary Embolism Care
  • Appendix
  • Methodology
  • About the Analyst
  • Contact Us
  • Disclaimer
List of Tables
  • AngioDynamics Inc Pipeline Products and Ongoing Clinical Trials Overview
  • AngioDynamics Inc Pipeline Products by Equipment Type
  • AngioDynamics Inc Pipeline Products by Indication
  • AngioDynamics Inc Ongoing Clinical Trials by Trial Status
  • AngioDynamics Inc, Key Facts
  • AngioDynamics Inc, Major Products and Services
  • AngioDynamics Inc Number of Pipeline Products by Development Stage
  • AngioDynamics Inc Pipeline Products Summary by Development Stage
  • AngioDynamics Inc Ongoing Clinical Trials by Trial Status
  • AngioDynamics Inc Ongoing Clinical Trials Summary
  • Acuswift - Product Status
  • Acuswift - Product Description
  • AlphaReturn Blood Management System - Product Status
  • AlphaReturn Blood Management System - Product Description
  • AlphaReturn Blood Management System - Acute Pulmonary Embolism Treatment With the AlphaVac Multipurpose Mechanical Aspiration System and the AlphaReturn Blood Management System: Evaluation of Safety and Effectiveness (APEX-Return)
  • Alphavac F13 10 - Product Status
  • Alphavac F13 10 - Product Description
  • Alphavac F14 20 - Product Status
  • Alphavac F14 20 - Product Description
  • AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System - Product Status
  • AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System - Product Description
  • AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System - Acute Pulmonary Embolism Treatment With the AlphaVac Multipurpose Mechanical Aspiration System and the AlphaReturn Blood Management System: Evaluation of Safety and Effectiveness (APEX-Return)
  • AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System - Prospective, Multicenter, Multi-national, Single Arm Trial Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism Using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System
  • AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System - Product Status
  • AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System - Product Description
  • AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System - Acute Pulmonary Embolism Treatment With the AlphaVac Multipurpose Mechanical Aspiration System and the AlphaReturn Blood Management System: Evaluation of Safety and Effectiveness (APEX-Return)
  • AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System - Prospective, Multicenter, Multi-national, Single Arm Trial Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism Using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System
  • Alphavac System - Infective Endocarditis - Product Status
  • Alphavac System - Infective Endocarditis - Product Description
  • Alphavac System - Left Atrial Appendage Thrombus - Product Status
  • Alphavac System - Left Atrial Appendage Thrombus - Product Description
  • AngioVac - Generation 4 - Product Status
  • AngioVac - Generation 4 - Product Description
  • AngioVac - Left Heart - Product Status
  • AngioVac - Left Heart - Product Description
  • AngioVac Low Profile Catheter - Product Status
  • AngioVac Low Profile Catheter - Product Description
  • AngioVac System - Infective Endocarditis - Product Status
  • AngioVac System - Infective Endocarditis - Product Description
  • AngioVac System - Infective Endocarditis - Feasibility Protocol for Percutaneous AngioVac Vegetation Extraction (PAVE) to Remove Right Heart Vegetations in Patients With Infective Endocarditis
  • AURYON Atherectomy System - Gastrointestinal Procedures - Product Status
  • AURYON Atherectomy System - Gastrointestinal Procedures - Product Description
  • AURYON Atherectomy System - Iliofemoral Deep Vein Thrombosis (DVT) - Product Status
  • AURYON Atherectomy System - Iliofemoral Deep Vein Thrombosis (DVT) - Product Description
  • AURYON Atherectomy System - Lead Extraction - Product Status
  • AURYON Atherectomy System - Lead Extraction - Product Description
  • AURYON Atherectomy System - Venous Disease - Product Status
  • AURYON Atherectomy System - Venous Disease - Product Description
  • AURYON System - Small Vessel Thrombectomy - Product Status
  • AURYON System - Small Vessel Thrombectomy - Product Description
  • Automated Fluid Management System - Product Status
  • Automated Fluid Management System - Product Description
  • BioFlo PICC Line Extension - Product Status
  • BioFlo PICC Line Extension - Product Description
  • BioFlo Portline Line Extension - Product Status
  • BioFlo Portline Line Extension - Product Description
  • Coronary Angio Catheter - Product Status
  • Coronary Angio Catheter - Product Description
  • FireFly Tip Location - Product Status
  • FireFly Tip Location - Product Description
  • Inflation Device - Product Status
  • Inflation Device - Product Description
  • Mechanical Thrombectomy Device - Product Status
  • Mechanical Thrombectomy Device - Product Description
  • Multi-Purpose Mechanical Aspiration Gen 2 - Product Status
  • Multi-Purpose Mechanical Aspiration Gen 2 - Product Description
  • NanoKnife 3.0 System - Liver Cancer - Product Status
  • NanoKnife 3.0 System - Liver Cancer - Product Description
  • NanoKnife 3.0 System - Pancreatic Cancer - Product Status
  • NanoKnife 3.0 System - Pancreatic Cancer - Product Description
  • NanoKnife 3.0 System - Prostate Cancer - Product Status
  • NanoKnife 3.0 System - Prostate Cancer - Product Description
  • NanoKnife System - Benign Prostatic Hyperplasia - Product Status
  • NanoKnife System - Benign Prostatic Hyperplasia - Product Description
  • NanoKnife System - Benign Prostatic Hyperplasia - Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)
  • Nanoknife System - Bladder Cancer - Product Status
  • Nanoknife System - Bladder Cancer - Product Description
  • NanoKnife System - Cervical Cancer - Product Status
  • NanoKnife System - Cervical Cancer - Product Description
  • NanoKnife System - Head And Neck Cancer - Product Status
  • NanoKnife System - Head And Neck Cancer - Product Description
  • NanoKnife System - Hepatocellular Carcinoma - Product Status
  • NanoKnife System - Hepatocellular Carcinoma - Product Description
  • NanoKnife System - Hepatocellular Carcinoma - An International, Multi-centre, Registry-based, Phase II Study of the Treatment of LIVER-limited HepatoCellular Carcinoma (HCC) in Patients With Preserved Liver Function by IRreversible Electroporation.
  • NanoKnife System - Hepatocellular Carcinoma - Treatment of LIVER METastases From Colorectal Cancer by IRreversible Electroporation: A Prospective, International, Multi-centre Cohort Study.
  • NanoKnife System - Lung Cancer - Product Status
  • NanoKnife System - Lung Cancer - Product Description
  • Nanoknife System - Metastatic Lymph Nodes - Product Status
  • Nanoknife System - Metastatic Lymph Nodes - Product Description
  • NanoKnife System - Rectal Cancer - Product Status
  • NanoKnife System - Rectal Cancer - Product Description
  • NanoKnife System - Stage III Pancreatic Cancer - Product Status
  • NanoKnife System - Stage III Pancreatic Cancer - Product Description
  • NanoKnife System - Stage III Pancreatic Cancer - A Randomized, Multicenter, Controlled, Unblinded Study to Assess the Safety and Efficacy of the NanoKnife System for the Ablation of Unresectable Stage 3 Pancreatic Adenocarcinoma
  • NanoKnife System - Stage III Pancreatic Cancer - Evaluation of the Short and Intermediate Term Outcomes of Ablation of Locally Advanced Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System - A Prospective Study
  • NanoKnife System - Stage III Pancreatic Cancer - Registry to Evaluate Effectiveness and Safety of the NanoKnife System for the Ablation of Stage 3 Pancreatic Adenocarcinoma
  • NanoKnife System - Stage III Pancreatic Cancer - Systemic Therapy with a Loco-regional Treatment in Patients with Locally Advanced Pancreatic Cancer: The SMART Study
  • Nanoknife System - Stomach Neoplasm - Product Status
  • Nanoknife System - Stomach Neoplasm - Product Description
  • Nanoknife System - Unresectable Renal Pelvis Urothelial Neoplasm - Product Status
  • Nanoknife System - Unresectable Renal Pelvis Urothelial Neoplasm - Product Description
  • Next Gen Tumescent Delivery Device - Product Status
  • Next Gen Tumescent Delivery Device - Product Description
  • Next Generation BioFlo PICC - Product Status
  • Next Generation BioFlo PICC - Product Description
  • Next Generation BioFlo Port - Product Status 7
  • Next Generation BioFlo Port - Product Description 7
  • Next Generation Dialysis Device - Product Status
  • Next Generation Dialysis Device - Product Description
  • Next Generation Laser - Product Status
  • Next Generation Laser - Product Description
  • Next Generation Radio Frequency Ablation System - Product Status
  • Next Generation Radio Frequency Ablation System - Product Description
  • Non-Thermal Vein Ablation Device - Product Status
  • Non-Thermal Vein Ablation Device - Product Description
  • Peripheral Vascular Drainage Line Extension - Product Status
  • Peripheral Vascular Drainage Line Extension - Product Description
  • POWERWAVE - Product Status
  • POWERWAVE - Product Description
  • Smart Port - Dual - Product Status
  • Smart Port - Dual - Product Description
  • Ultrasound-Assisted Thrombectomy System - Product Status
  • Ultrasound-Assisted Thrombectomy System - Product Description
  • AngioDynamics Inc, Key Employees 7
  • AngioDynamics Inc, Key Employee Biographies
  • AngioDynamics Inc, Other Locations
  • AngioDynamics Inc, Subsidiaries
  • Glossary 8
List of Figures
  • AngioDynamics Inc Pipeline Products by Equipment Type
  • AngioDynamics Inc Pipeline Products by Development Stage
  • AngioDynamics Inc Ongoing Clinical Trials by Trial Status

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Total Vein Systems
  • Smiths Medical
  • Medtronic Plc
  • CR Bard Inc
  • Terumo Medical Corp
  • Medical Components Inc
  • Merit Medical Systems Inc
  • Johnson & Johnson
  • Boston Scientific Corp
  • Cook Medical LLC
  • Varian Medical Systems Inc
  • Teleflex Inc
  • Inari Medical Inc